Works matching IS 13657852 AND DT 2009 AND VI 12 AND IP 1

Results: 19

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 94, doi. 10.1038/pcan.2008.10
By:
- Tucci, M.;
- Mosca, A.;
- Lamanna, G.;
- Porpiglia, F.;
- Terzolo, M.;
- Vana, F.;
- Cracco, C.;
- Russo, L.;
- Gorzegno, G.;
- Tampellini, M.;
- Torta, M.;
- Reimondo, G.;
- Poggio, M.;
- Scarpa, R. M.;
- Angeli, A.;
- Dogliotti, L.;
- Berruti, A.
Publication type:
Article
Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 52, doi. 10.1038/pcan.2008.26
By:
- Lee, U. J.;
- Jones, J. S.
Publication type:
Article
Probability of finding T1a and T1b (Incidental) prostate cancer during TURP has decreased in the PSA era.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 57, doi. 10.1038/pcan.2008.14
By:
- Jones, J. S.;
- Follis, H. W.;
- Johnson, J. R.
Publication type:
Article
Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 61, doi. 10.1038/pcan.2008.17
By:
- Nobes, J. P.;
- Wells, I. G.;
- Khaksar, S. J.;
- Money-Kyrle, J. F.;
- Laing, R. W.;
- Langley, S. E. M.
Publication type:
Article
Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 83, doi. 10.1038/pcan.2008.52
By:
- Tunn, U. W.;
- Wiedey, K.
Publication type:
Article
Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 17, doi. 10.1038/pcan.2008.19
By:
- Costello, L. C.;
- Franklin, R. B.
Publication type:
Article
Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 25, doi. 10.1038/pcan.2008.23
By:
- St John Floyd Jr., M.;
- Teahan, S. J.;
- Fitzpatrick, J. M.;
- Watson, R. W. G.
Publication type:
Article
Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 100, doi. 10.1038/pcan.2008.15
By:
- Spitz, I. M.;
- Chertin, B.;
- Fridmans, A.;
- Farkas, A.;
- Belanger, A.;
- Hartman, H.;
- Labrie, F.
Publication type:
Article
Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 34, doi. 10.1038/pcan.2008.27
By:
- Nakano, Y.;
- Bilim, V.;
- Yuuki, K.;
- Muto, A.;
- Kato, T.;
- Nagaoka, A.;
- Tomita, Y.
Publication type:
Article
Distress and social dysfunction following prostate cancer treatment: a longitudinal cross-cultural comparison of Japanese and American men.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 67, doi. 10.1038/pcan.2008.20
By:
- Namiki, S.;
- Kwan, L.;
- Kagawa-Singer, M.;
- Terai, A.;
- Satoh, T.;
- Baba, S.;
- Arai, Y.;
- Litwin, M. S.
Publication type:
Article
Prostate News.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 2, doi. 10.1038/pcan.2008.59
Publication type:
Article
Prostate cancer chemotherapy in the era of targeted therapy.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 13, doi. 10.1038/pcan.2008.32
By:
- Michael, A.;
- Syrigos, K.;
- Pandha, H.
Publication type:
Article
Quality of life in patients with prostate cancer: development and application of a hybrid assessment method.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 72, doi. 10.1038/pcan.2008.28
By:
- Stone, P. C.;
- Murphy, R. F.;
- Matar, H. E.;
- Almerie, M. Q.
Publication type:
Article
HIV and prostate cancer: a systematic review of the literature.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 6, doi. 10.1038/pcan.2008.44
By:
- Silberstein, J.;
- Downs, T.;
- Lakin, C.;
- Kane, C. J.
Publication type:
Article
Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 41, doi. 10.1038/pcan.2008.33
By:
- Welén, K.;
- Jennbacken, K.;
- Tes̆an, T.;
- Damber, J.-E.
Publication type:
Article
Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients?
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 78, doi. 10.1038/pcan.2008.35
By:
- Imamoto, T.;
- Suzuki, H.;
- Yano, M.;
- Kawamura, K.;
- Kamiya, N.;
- Araki, K.;
- Komiya, A.;
- Naya, Y.;
- ShiraishI, T.;
- Ichikawa, T.
Publication type:
Article
The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 88, doi. 10.1038/pcan.2008.36
By:
- Armstrong, A. J.;
- Halabi, S.;
- De Wit, R.;
- Tannock, I. F.;
- Eisenberger, M.
Publication type:
Article
Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 47, doi. 10.1038/pcan.2008.37
By:
- Connolly, D.;
- Black, A.;
- Murray, L. J.;
- Nambirajan, T.;
- Keane, P. F.;
- Gavin, A.
Publication type:
Article
Report from Durham.
Published in:
Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 1, doi. 10.1038/pcan.2009.1
By:
- Moul, J.
Publication type:
Article